The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The debate will start after the conclusion of the other parliamentary business scheduled that day, which is likely to be around 10pm. It will be led by Neale Hanvey MP.
Watch the debate here on Wednesday: https://parliamentlive.tv/Event/Index/3269e80b-8ea7-452a-bd7e-ca4c2f33147f
You'll be able to read a transcript of the debate a few hours after it happens: https://hansard.parliament.uk/commons/2022-01-05
Watch the debate here on Wednesday: https://parliamentlive.tv/Event/Index/3269e80b-8ea7-452a-bd7e-ca4c2f33147f
You recently signed the petition “Hold a public inquiry into Government contracts granted during Covid-19”:
https://petition.parliament.uk/petitions/328408
MPs will debate the award of public contracts to private companies during the covid-19 outbreak on Wednesday 5 January in the main House of Commons chamber. This is an adjournment debate.
Adjournment debates are half-hour debates at the end of each day's sitting. They are an opportunity for an individual backbench MP to raise an issue and receive a response from the relevant Minister, however they do not end in a vote nor can they change the law.
The debate will start after the conclusion of the other parliamentary business scheduled that day, which is likely to be around 10pm. It will be led by Neale Hanvey MP.
Watch the debate here on Wednesday: https://parliamentlive.tv/Event/Index/3269e80b-8ea7-452a-bd7e-ca4c2f33147f
You'll be able to read a transcript of the debate a few hours after it happens: https://hansard.parliament.uk/commons/2022-01-05
Find out more about how adjournment debates work:
https://www.parliament.uk/about/how/business/debates/adjournment/
Get involved in the work of the UK Parliament
You can sign up to the UK Parliament newsletter for the latest information on how to get involved and make a difference: https://learning.parliament.uk/en/your-uk-parliament-newsletter-sign-up-form/
Thanks,
The Petitions team
UK Government and Parliament
You’re receiving this email because you signed this petition: “Hold a public inquiry into Government contracts granted during Covid-19”.
To unsubscribe from getting emails about this petition: https://petition.parliament.uk/signatures/96354467/unsubscribe?token=1Tn6gh92ZxVRP_PPovuQ
Fantastic piece, Ninks - just sent off an email to Kier and left a message on his voice mail asking someone to read it. Lets fill up his email in box and his voicemail box! 0207 219 6234. keir.starmer.mp@parliament.uk
If you are emailing me in my role as Leader of the Opposition, your message has been successfully received and we will do our very best to respond. Let's do it!!!!!!!
Who would have thought that after starting a little, innocent thread 'Hmmmm' last night at 21.39 it is still going strong nearly 24 hours later and apparently AgentB (whom I've filtered anyway) has wound a lot of people up!!!!
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce its proposed Admission to trading on AIM and its conditional placing of 9,202,094 new Ordinary Shares (the "New Shares"), at a price of 117 pence per share (the "Placing Price") with institutional and other investors. Based on the Placing Price, the Company's market capitalisation on Admission will be approximately £80.7 million.
Confirmation of detection of Omicron variant
OMEGA DIAGNOSTICS GROUP PLC
Released 07:00:11 14 December 2021
RNS Number : 5063V
Omega Diagnostics Group PLC
14 December 2021
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Confirmation of detection of Omicron variant
VISITECT® COVID-19 antigen test performs with the same high accuracy on the Omicron variant
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, has been notified by its technology partner Mologic Ltd ("Mologic") that data from analysis on clinical samples, as well as in-silico analysis, show that the Mologic Covios® Ag lateral flow test, performs with the same high accuracy on the Omicron variant as it does with existing known variants.
This is the same test that is manufactured and sold for professional use by Omega as the VISITECT® COVID-19 antigen test.
Colin King, CEO, Omega Diagnostics, said: "We are very pleased be in a position to confirm that the VISITECT® COVID-19 antigen test is able to equally detect the Omicron variant, as well as other existing variants. We remain encouraged by emerging commercial opportunities for our VISITECT® COVID-19 Antigen test that we expect to be unlocked following relevant approval under CTDA regulations and CE-marking for home-use."